We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

Public consultation process launched on draft addendum to the guideline for good clinical practice

07 September 2015

Focus on Regulation – Hogan Lovells Blog

On 4 August 2015, the Committee for Medicinal Products for Human Use (“CHMP”) launched a six month public consultation process on a draft addendum to the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) E6 (R2) Guideline for good clinical practice.

To read more, click here.


Loading data